Allan Prochazka
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 11 | 2023 | 435 | 1.850 |
Why?
| | Preventive Health Services | 5 | 2020 | 154 | 0.910 |
Why?
| | Internal Medicine | 7 | 2016 | 276 | 0.900 |
Why?
| | Informed Consent | 6 | 2022 | 195 | 0.900 |
Why?
| | Diagnostic Tests, Routine | 3 | 2014 | 110 | 0.810 |
Why?
| | Disease | 2 | 2013 | 99 | 0.750 |
Why?
| | Health Status Indicators | 2 | 2013 | 161 | 0.740 |
Why?
| | Early Diagnosis | 2 | 2013 | 247 | 0.730 |
Why?
| | Hospitalists | 3 | 2013 | 248 | 0.700 |
Why?
| | Cancer Survivors | 5 | 2025 | 296 | 0.680 |
Why?
| | Physical Examination | 3 | 2015 | 245 | 0.660 |
Why?
| | Down Syndrome | 3 | 2021 | 522 | 0.620 |
Why?
| | Stress Disorders, Post-Traumatic | 3 | 2016 | 872 | 0.540 |
Why?
| | Motivational Interviewing | 3 | 2016 | 118 | 0.530 |
Why?
| | Weight Reduction Programs | 2 | 2016 | 125 | 0.510 |
Why?
| | Anticoagulants | 3 | 2007 | 728 | 0.480 |
Why?
| | Varenicline | 1 | 2016 | 28 | 0.480 |
Why?
| | Quality of Health Care | 4 | 2018 | 650 | 0.470 |
Why?
| | Comprehension | 3 | 2014 | 181 | 0.460 |
Why?
| | Internship and Residency | 5 | 2016 | 1251 | 0.460 |
Why?
| | Patient Readmission | 4 | 2015 | 706 | 0.440 |
Why?
| | Veterans | 8 | 2023 | 1564 | 0.440 |
Why?
| | Nicotinic Agonists | 1 | 2016 | 136 | 0.430 |
Why?
| | Patient Satisfaction | 3 | 2015 | 701 | 0.410 |
Why?
| | Telemedicine | 3 | 2023 | 930 | 0.410 |
Why?
| | Educational Measurement | 1 | 2016 | 324 | 0.400 |
Why?
| | Telenursing | 1 | 2013 | 10 | 0.390 |
Why?
| | Warfarin | 2 | 2005 | 168 | 0.390 |
Why?
| | Combat Disorders | 1 | 2013 | 41 | 0.390 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 180 | 0.380 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 285 | 0.380 |
Why?
| | Students, Medical | 2 | 2016 | 372 | 0.370 |
Why?
| | Iraq War, 2003-2011 | 1 | 2013 | 163 | 0.370 |
Why?
| | Afghan Campaign 2001- | 1 | 2013 | 183 | 0.360 |
Why?
| | Hospitalization | 4 | 2016 | 2317 | 0.360 |
Why?
| | Gastric Bypass | 1 | 2013 | 123 | 0.360 |
Why?
| | Bibliometrics | 1 | 2012 | 59 | 0.350 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 251 | 0.350 |
Why?
| | Patient Discharge | 3 | 2015 | 923 | 0.350 |
Why?
| | Preoperative Care | 1 | 2014 | 383 | 0.340 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1044 | 0.340 |
Why?
| | Depression | 4 | 2026 | 1516 | 0.340 |
Why?
| | Humans | 66 | 2026 | 143875 | 0.330 |
Why?
| | Publishing | 1 | 2012 | 111 | 0.330 |
Why?
| | Overweight | 1 | 2015 | 598 | 0.320 |
Why?
| | Adult | 28 | 2026 | 40114 | 0.310 |
Why?
| | Tobacco Use Disorder | 3 | 2023 | 237 | 0.310 |
Why?
| | Weight Loss | 1 | 2015 | 812 | 0.300 |
Why?
| | Obesity, Morbid | 1 | 2013 | 278 | 0.300 |
Why?
| | Primary Health Care | 3 | 2015 | 1780 | 0.300 |
Why?
| | Lung Neoplasms | 4 | 2023 | 2583 | 0.290 |
Why?
| | Ethics, Medical | 2 | 2012 | 83 | 0.290 |
Why?
| | United States | 18 | 2021 | 15592 | 0.280 |
Why?
| | Smoking | 4 | 2017 | 1580 | 0.280 |
Why?
| | Publications | 1 | 2008 | 48 | 0.270 |
Why?
| | Aged | 20 | 2023 | 25376 | 0.270 |
Why?
| | Attitude of Health Personnel | 4 | 2016 | 1207 | 0.260 |
Why?
| | Ofloxacin | 2 | 2005 | 17 | 0.260 |
Why?
| | Levofloxacin | 2 | 2005 | 20 | 0.260 |
Why?
| | International Normalized Ratio | 2 | 2005 | 50 | 0.260 |
Why?
| | Research Design | 2 | 2020 | 1125 | 0.250 |
Why?
| | Vena Cava Filters | 1 | 2007 | 64 | 0.250 |
Why?
| | Physicians | 5 | 2016 | 940 | 0.250 |
Why?
| | Rheumatology | 1 | 2008 | 123 | 0.250 |
Why?
| | Physician-Patient Relations | 5 | 2015 | 589 | 0.250 |
Why?
| | Quality of Life | 6 | 2026 | 3085 | 0.250 |
Why?
| | Middle Aged | 23 | 2026 | 35428 | 0.240 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2010 | 97 | 0.240 |
Why?
| | Male | 30 | 2026 | 71700 | 0.230 |
Why?
| | Rehabilitation Centers | 2 | 2015 | 39 | 0.230 |
Why?
| | Pulmonary Embolism | 1 | 2007 | 239 | 0.220 |
Why?
| | Obesity | 2 | 2016 | 3046 | 0.220 |
Why?
| | Nortriptyline | 1 | 2004 | 10 | 0.220 |
Why?
| | Physicians, Family | 2 | 2009 | 192 | 0.220 |
Why?
| | Female | 31 | 2026 | 77454 | 0.220 |
Why?
| | Medical Staff, Hospital | 2 | 2016 | 81 | 0.210 |
Why?
| | Communication | 5 | 2014 | 956 | 0.210 |
Why?
| | Resilience, Psychological | 1 | 2026 | 137 | 0.210 |
Why?
| | Teaching Rounds | 2 | 2016 | 73 | 0.200 |
Why?
| | Biomarkers | 2 | 2022 | 4244 | 0.200 |
Why?
| | Burnout, Professional | 2 | 2010 | 465 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2015 | 102 | 0.190 |
Why?
| | Telerehabilitation | 1 | 2023 | 43 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 243 | 0.190 |
Why?
| | Confidence Intervals | 3 | 2021 | 332 | 0.190 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2004 | 181 | 0.180 |
Why?
| | Spinal Cord Injuries | 1 | 2026 | 238 | 0.180 |
Why?
| | Surveys and Questionnaires | 12 | 2021 | 6036 | 0.180 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2025 | 197 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.180 |
Why?
| | Hearing Aids | 1 | 2023 | 88 | 0.180 |
Why?
| | Follow-Up Studies | 6 | 2018 | 5319 | 0.180 |
Why?
| | Nicotine | 1 | 2004 | 343 | 0.180 |
Why?
| | Leisure Activities | 1 | 2021 | 30 | 0.170 |
Why?
| | Time Factors | 9 | 2021 | 7042 | 0.160 |
Why?
| | Smoking Prevention | 2 | 2017 | 170 | 0.160 |
Why?
| | Neoplasms | 3 | 2025 | 2812 | 0.160 |
Why?
| | Cohort Studies | 5 | 2018 | 5898 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2008 | 1414 | 0.160 |
Why?
| | Hearing Loss | 1 | 2023 | 240 | 0.150 |
Why?
| | Retrospective Studies | 7 | 2020 | 16797 | 0.150 |
Why?
| | Cross-Sectional Studies | 8 | 2026 | 5762 | 0.150 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 434 | 0.130 |
Why?
| | Odds Ratio | 2 | 2012 | 1060 | 0.130 |
Why?
| | Logistic Models | 4 | 2021 | 2109 | 0.130 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 28 | 0.130 |
Why?
| | Financing, Organized | 1 | 2016 | 35 | 0.120 |
Why?
| | Medicaid | 1 | 2020 | 460 | 0.120 |
Why?
| | Evidence-Based Medicine | 3 | 2016 | 724 | 0.120 |
Why?
| | Prenatal Care | 1 | 2018 | 303 | 0.120 |
Why?
| | Contraindications | 1 | 2015 | 86 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 954 | 0.120 |
Why?
| | Clinical Competence | 2 | 2014 | 1237 | 0.120 |
Why?
| | Learning | 2 | 2016 | 436 | 0.110 |
Why?
| | Preventive Medicine | 1 | 2015 | 40 | 0.110 |
Why?
| | Decision Support Systems, Management | 1 | 2015 | 6 | 0.110 |
Why?
| | Surgeons | 1 | 2020 | 336 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2018 | 241 | 0.110 |
Why?
| | Risk Assessment | 4 | 2015 | 3585 | 0.110 |
Why?
| | Disclosure | 2 | 2012 | 86 | 0.110 |
Why?
| | Patient Care | 1 | 2016 | 125 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2025 | 1675 | 0.110 |
Why?
| | Teaching | 1 | 2016 | 233 | 0.110 |
Why?
| | Pilot Projects | 3 | 2023 | 1839 | 0.110 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 744 | 0.100 |
Why?
| | Treatment Outcome | 7 | 2025 | 11390 | 0.100 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2014 | 47 | 0.100 |
Why?
| | Costs and Cost Analysis | 2 | 2013 | 220 | 0.100 |
Why?
| | Data Interpretation, Statistical | 2 | 2014 | 377 | 0.100 |
Why?
| | Medication Adherence | 1 | 2018 | 515 | 0.100 |
Why?
| | Curriculum | 2 | 2013 | 1047 | 0.100 |
Why?
| | Patient Transfer | 1 | 2015 | 177 | 0.100 |
Why?
| | Faculty, Medical | 1 | 2016 | 297 | 0.100 |
Why?
| | Incidental Findings | 1 | 2014 | 82 | 0.100 |
Why?
| | Guidelines as Topic | 2 | 2013 | 270 | 0.100 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 35 | 0.100 |
Why?
| | Drug Interactions | 2 | 2005 | 407 | 0.100 |
Why?
| | Inpatients | 2 | 2017 | 524 | 0.100 |
Why?
| | Nursing Homes | 1 | 2015 | 176 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2013 | 2782 | 0.090 |
Why?
| | Patient Care Management | 1 | 2013 | 55 | 0.090 |
Why?
| | Mental Recall | 1 | 2014 | 213 | 0.090 |
Why?
| | Research | 1 | 2016 | 439 | 0.090 |
Why?
| | Early Medical Intervention | 1 | 2013 | 60 | 0.090 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 257 | 0.090 |
Why?
| | Administration, Oral | 2 | 2005 | 842 | 0.090 |
Why?
| | Health Literacy | 1 | 2014 | 178 | 0.090 |
Why?
| | Pharmacists | 1 | 2015 | 260 | 0.090 |
Why?
| | Government Regulation | 1 | 2012 | 37 | 0.090 |
Why?
| | Morbidity | 1 | 2013 | 321 | 0.090 |
Why?
| | Self Care | 1 | 2015 | 388 | 0.090 |
Why?
| | Methotrexate | 1 | 2013 | 256 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2015 | 8077 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1362 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| | Risk | 1 | 2014 | 906 | 0.090 |
Why?
| | Perception | 1 | 2014 | 378 | 0.090 |
Why?
| | Primary Prevention | 1 | 2013 | 202 | 0.090 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2012 | 136 | 0.090 |
Why?
| | Nurse's Role | 1 | 2013 | 169 | 0.080 |
Why?
| | Adolescent | 5 | 2021 | 22529 | 0.080 |
Why?
| | Hospital Costs | 1 | 2012 | 123 | 0.080 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 202 | 0.080 |
Why?
| | Drug Therapy, Combination | 2 | 2004 | 1058 | 0.080 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 89 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2015 | 542 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2018 | 861 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 129 | 0.080 |
Why?
| | Mortality | 1 | 2013 | 364 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1061 | 0.080 |
Why?
| | Hospitals | 1 | 2015 | 691 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1562 | 0.080 |
Why?
| | Antirheumatic Agents | 1 | 2013 | 309 | 0.080 |
Why?
| | Work Schedule Tolerance | 2 | 2010 | 52 | 0.080 |
Why?
| | Decision Making | 2 | 2014 | 962 | 0.080 |
Why?
| | Information Dissemination | 1 | 2012 | 211 | 0.080 |
Why?
| | Colorado | 5 | 2020 | 4669 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2013 | 872 | 0.070 |
Why?
| | Health Care Surveys | 2 | 2015 | 565 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 446 | 0.070 |
Why?
| | Exercise | 1 | 2021 | 2166 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2014 | 3381 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 687 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2013 | 1051 | 0.070 |
Why?
| | Databases, Bibliographic | 1 | 2008 | 29 | 0.070 |
Why?
| | Counseling | 3 | 2023 | 399 | 0.070 |
Why?
| | Beneficence | 1 | 2008 | 20 | 0.070 |
Why?
| | Age Factors | 4 | 2015 | 3331 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1326 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 365 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 351 | 0.070 |
Why?
| | Job Satisfaction | 2 | 2010 | 230 | 0.070 |
Why?
| | Social Justice | 1 | 2008 | 85 | 0.070 |
Why?
| | Patient Care Team | 1 | 2013 | 692 | 0.070 |
Why?
| | Surgical Procedures, Operative | 1 | 2010 | 274 | 0.060 |
Why?
| | Alcoholism | 1 | 2014 | 839 | 0.060 |
Why?
| | Gastroenterology | 1 | 2009 | 186 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2012 | 783 | 0.060 |
Why?
| | Thromboembolism | 1 | 2007 | 126 | 0.060 |
Why?
| | Linear Models | 3 | 2014 | 860 | 0.060 |
Why?
| | Age Distribution | 1 | 2007 | 398 | 0.060 |
Why?
| | Child | 3 | 2020 | 22784 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1090 | 0.060 |
Why?
| | Colonoscopy | 1 | 2008 | 255 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 25 | 0.060 |
Why?
| | Quality Improvement | 1 | 2014 | 1267 | 0.060 |
Why?
| | Biomedical Research | 1 | 2012 | 699 | 0.060 |
Why?
| | Lung | 3 | 2023 | 4119 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 758 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 42 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2018 | 3013 | 0.050 |
Why?
| | Azithromycin | 1 | 2005 | 103 | 0.050 |
Why?
| | Administration, Cutaneous | 1 | 2004 | 129 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2006 | 279 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2026 | 219 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1219 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 364 | 0.050 |
Why?
| | Probability | 1 | 2004 | 308 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1294 | 0.050 |
Why?
| | Reference Values | 1 | 2004 | 811 | 0.050 |
Why?
| | Immunologic Tests | 1 | 2022 | 16 | 0.050 |
Why?
| | Hospitals, Veterans | 2 | 2017 | 255 | 0.050 |
Why?
| | HIV Infections | 1 | 2018 | 3018 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2004 | 774 | 0.050 |
Why?
| | Tobacco Products | 1 | 2023 | 91 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2004 | 2021 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 331 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2022 | 163 | 0.050 |
Why?
| | Fluoxetine | 1 | 2002 | 56 | 0.040 |
Why?
| | Public Opinion | 1 | 2002 | 60 | 0.040 |
Why?
| | Social Support | 1 | 2026 | 636 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2002 | 105 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 259 | 0.040 |
Why?
| | Health Behavior | 1 | 2007 | 791 | 0.040 |
Why?
| | Medicare | 2 | 2020 | 810 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 485 | 0.040 |
Why?
| | Risk Factors | 4 | 2021 | 10673 | 0.040 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 53 | 0.040 |
Why?
| | Young Adult | 2 | 2015 | 13998 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2013 | 2118 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2022 | 354 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 135 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 133 | 0.040 |
Why?
| | Data Collection | 2 | 2013 | 655 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2057 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2008 | 835 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 234 | 0.040 |
Why?
| | Prospective Studies | 2 | 2018 | 7918 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Continuity of Patient Care | 2 | 2014 | 284 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 505 | 0.040 |
Why?
| | Behavior Therapy | 1 | 2002 | 283 | 0.040 |
Why?
| | Length of Stay | 2 | 2015 | 1285 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1758 | 0.040 |
Why?
| | Attitude to Health | 1 | 2002 | 452 | 0.040 |
Why?
| | Walking | 1 | 2023 | 557 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2017 | 1167 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2010 | 1315 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2002 | 575 | 0.030 |
Why?
| | Community Health Services | 1 | 2018 | 234 | 0.030 |
Why?
| | Formative Feedback | 1 | 2016 | 29 | 0.030 |
Why?
| | Behavior | 1 | 2016 | 92 | 0.030 |
Why?
| | Self Report | 1 | 2021 | 878 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2002 | 591 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2832 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 824 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2016 | 176 | 0.030 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 2014 | 9 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 771 | 0.030 |
Why?
| | Alaska | 1 | 2014 | 85 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2014 | 304 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2016 | 535 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 890 | 0.030 |
Why?
| | Physician-Nurse Relations | 1 | 2013 | 18 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 115 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2016 | 374 | 0.020 |
Why?
| | Health Services Research | 1 | 2015 | 402 | 0.020 |
Why?
| | Models, Psychological | 1 | 2014 | 313 | 0.020 |
Why?
| | Patient Rights | 1 | 2012 | 11 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| | Focus Groups | 1 | 2014 | 570 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2012 | 55 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 1003 | 0.020 |
Why?
| | Computer-Assisted Instruction | 1 | 2012 | 69 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 938 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 155 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 61 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2016 | 546 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 206 | 0.020 |
Why?
| | Patient Care Planning | 1 | 2012 | 162 | 0.020 |
Why?
| | Seizures | 1 | 2014 | 454 | 0.020 |
Why?
| | Physician's Role | 1 | 2012 | 218 | 0.020 |
Why?
| | Documentation | 1 | 2012 | 197 | 0.020 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2010 | 52 | 0.020 |
Why?
| | Endarterectomy, Carotid | 1 | 2010 | 55 | 0.020 |
Why?
| | Motivation | 1 | 2015 | 611 | 0.020 |
Why?
| | Prostatectomy | 1 | 2010 | 102 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2012 | 322 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 527 | 0.020 |
Why?
| | Pregnancy | 2 | 2018 | 7169 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2097 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 624 | 0.020 |
Why?
| | Observation | 1 | 2008 | 56 | 0.020 |
Why?
| | Patient Participation | 1 | 2012 | 434 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 464 | 0.020 |
Why?
| | Health Personnel | 1 | 2014 | 736 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1877 | 0.020 |
Why?
| | Medicine | 1 | 2009 | 125 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 445 | 0.020 |
Why?
| | Postoperative Care | 1 | 2009 | 282 | 0.020 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2010 | 190 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1028 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2181 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 581 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2939 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2087 | 0.010 |
Why?
| | Registries | 1 | 2013 | 2245 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2009 | 814 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1511 | 0.010 |
Why?
| | Reimbursement Mechanisms | 1 | 2002 | 82 | 0.010 |
Why?
| | Telephone | 1 | 2002 | 181 | 0.010 |
Why?
| | Medical Records | 1 | 2002 | 185 | 0.010 |
Why?
| | Anxiety | 1 | 2008 | 1093 | 0.010 |
Why?
| | Regression Analysis | 1 | 2002 | 1014 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 177 | 0.010 |
Why?
| | Mass Screening | 1 | 2008 | 1337 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2002 | 1254 | 0.010 |
Why?
| | Health Promotion | 1 | 2002 | 764 | 0.010 |
Why?
|
|
Prochazka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|